AIM ImmunoTech Inc. Common Stock Shares Outstanding

Quick Answer

AIM ImmunoTech Inc. reported Common Stock Shares Outstanding of 3.07 million shares for the year ending 2025.

  • AIM ImmunoTech Inc. showed an increase of +368.5% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2011: 135.46 million shares | Q3 2011: 135.54 million shares | Q1 2012: 135.83 million shares | Q2 2012: 136.22 million shares | Q3 2012: 147.51 million shares | Q1 2013: 167.07 million shares | Q2 2013: 167.23 million shares | Q3 2013: 167.55 million shares | Q1 2014: 183.29 million shares | Q2 2014: 189.50 million shares | Q3 2014: 193.71 million shares | Q1 2015: 225.74 million shares | Q2 2015: 245.48 million shares | Q3 2015: 247.56 million shares | Q1 2016: 247.57 million shares | Q2 2016: 248.83 million shares | Q3 2016: 24.11 million shares | Q1 2017: 26.19 million shares | Q2 2017: 28.96 million shares | Q3 2017: 31.08 million shares | Q1 2018: 39.22 million shares | Q2 2018: 46.82 million shares | Q3 2018: 47.96 million shares | Q1 2019: 62.90 million shares | Q2 2019: 2.21 million shares | Q3 2019: 6.10 million shares | Q1 2020: 28.05 million shares | Q2 2020: 34.25 million shares | Q3 2020: 40.69 million shares | Q1 2021: 47.83 million shares | Q2 2021: 47.83 million shares | Q3 2021: 47.85 million shares | Q1 2022: 47.99 million shares | Q2 2022: 48.05 million shares | Q3 2022: 48.08 million shares | Q1 2023: 48.41 million shares | Q2 2023: 48.42 million shares | Q3 2023: 48.80 million shares | Q1 2024: 50.25 million shares | Q2 2024: 57.14 million shares | Q3 2024: 58.67 million shares | Q1 2025: 72.29 million shares | Q2 2025: 764,188 shares | Q3 2025: 2.76 million shares.
  • Over the full 16 years of available data (2010 to 2025), AIM ImmunoTech Inc.'s Common Stock Shares Outstanding has declined by 97.7%.
  • Historical annual values: Fiscal year 2025: 3.07 million shares | Fiscal year 2024: 655,262 shares | Fiscal year 2023: 49.10 million shares | Fiscal year 2022: 48.08 million shares | Fiscal year 2021: 47.99 million shares | Fiscal year 2020: 42.15 million shares | Fiscal year 2019: 10.39 million shares | Fiscal year 2018: 1.11 million shares | Fiscal year 2017: 32.88 million shares | Fiscal year 2016: 24.20 million shares | Fiscal year 2015: 20.63 million shares | Fiscal year 2014: 204.00 million shares | Fiscal year 2013: 168.66 million shares | Fiscal year 2012: 166.49 million shares | Fiscal year 2011: 135.64 million shares | Fiscal year 2010: 135.24 million shares.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: